(Q44754575)

English

Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta

scientific article published in February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

multiple sclerosis

0 references

4

object named as

Hans Link

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Yu-Min Huang-Link

5

object named as

Yu-Min Huang

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Yassir Hussien

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Alessandra Sanna

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Mats Söderström

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

16-25

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Mechanisms of action of glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Self glycolipids as T-cell autoantigens

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Inflammation and therapeutic vaccination in CNS diseases

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

A case of mistaken identity

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS979OA

21 January 2018

Identifiers

10.1191/1352458504MS979OA

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44754575&oldid=2037520916"